Similarly, augmented SIRT3 deacetylase activity mediated reprogramming of mitochondria oxidative phosphorylation confers AML chemoresistance via induction of SOD2 activity and inhibition of mitochondria ROS production in AML cell lines in response to ara-C [14]. This evidence concerns the gene SIRT3 and acute myeloid leukemia.